Better Nights, Better Days for Children With Neurodevelopment Disorders

Launched by IWK HEALTH CENTRE · Feb 23, 2016

Keywords

ClinConnect Summary

The purpose of the study is to develop and evaluate a web-based intervention for insomnia among children with neurodevelopmental disabilities (NDD), including Autism Spectrum Disorder (ASD), Fetal Alcohol Spectrum Disorder (FASD), Cerebral Palsy (CP), and Attention-Deficit/Hyperactivity Disorder (ADHD). Using the internet to deliver an intervention program for insomnia in children will address access barriers and provide evidence-based treatment to large numbers of children with NDD.

This study will adapt the Better Nights, Better Days (BNBD) e-intervention that was developed for typically...

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. are the primary caregiver of a child aged 4 to 12 years
• • 2. live in any province/territory in Canada
• • 3. have regular access to a high-speed internet connection and an email account
• • 4. fluent in English or French
• • 5. have self-reported listening and reading comprehension level of grade 6 or higher
• • 6. have a child with ASD, CP, FASD, or ADHD, with level of impairment ranging from mild to moderate, in addition to insomnia
• Exclusion Criteria:
• • 1. caregiver wishes to "bed-share" with child
• • 2. child has a probable intrinsic sleep disorder (e.g., sleep apnea)
• • 3. child has a significant medical disorder that interferes with sleep (e.g., nighttime asthma attacks, tube-feeding, severe developmental disability affecting sensory systems such as vision)
• • 4. child has a mental health disorder that has required hospitalization or residential care
• • 5. child is non-ambulatory
• • 6. child experiences enuresis at least 3 times per week that requires parental intervention during the night
• • 7. child has a functional impairment below the 2nd percentile as determined by a caregiver report measure, the Adaptive Behavior Assessment System, 2nd Edition (ABAS-II)
• • 8. child is currently being treated with anti-epileptic and/or psychotropic medications (e.g., stimulant medication for ADHD) and the medication or dose is not stable and/or expected to change within 6 months